Abstrakti
| Alkuperäiskieli | Englanti |
|---|---|
| Sivut | 233-240 |
| Sivumäärä | 8 |
| Julkaisu | Future Microbiology |
| Vuosikerta | 15 |
| Numero | 4 |
| DOI - pysyväislinkit | |
| Tila | Julkaistu - 2020 |
| OKM-julkaisutyyppi | A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä |
Rahoitus
This study was financially supported by the following agents: Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9s045, 151B03, 9T044, 9U042, 150618, 9U042, 9V044, 9X040 and X51001); Academy of Finland: grant 286284; Finnish Foundation for Cardiovascular Research, Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association and EU Horizon 2020 (grant 755320 for TAXINOMISIS) and Tampere University Hospital Supporting Foundation. Anton Kontunen, Markus Karjalainen, Osmo Anttalainen, Niku Oksala and Antti Roine are shareholders of Olfactomics Ltd, which is about to commercialise proprietary technology for the detection of diseases by ion mobility spectrometry. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
Tutkimusalat
- DMS
- IMS
- bacteria
- differential mobility spectrometry
- eNose
- ion mobility spectrometry
Julkaisufoorumi-taso
- Jufo-taso 1
Sormenjälki
Sukella tutkimusaiheisiin 'Differential mobility spectrometry classification of bacteria'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.Siteeraa tätä
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver